How connected medical devices can slow COVID-19 spread in hospitals

Matthew Laskowski, CEO of Toby, discusses the machine learning and biomarker analysis technology behind the company’s urine-based multi-cancer detection test that has received FDA Breakthrough Device designation in the United States.

To get ROI, execs need to apply technology at scale, says former HCA CFO Bill Rutherford, who is now on the Board of Mangers at Ensemble Health Partners.

With predictive risk scores and care management data, providers can proactively target "high and rising risk populations" and treat behavioral health with urgency, says Yagnesh Vadgama, VP of payor strategy and network development at CentralReach.